The US Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for use of ACTEMRA to treat coronavirus disease 2019 (COVID-19) in pediatric patients (two years of age and older) who are in the hospital and who are receiving corticosteroids and require supplemental oxygen, or a machine that helps with their breathing (ventilator) or a machine that adds oxygen to the blood outside the body (extracorporeal membrane oxygenation or ECMO). ACTEMRA is not FDA-approved for use in pediatric patients with COVID-19.
Download the EUA Patient Fact Sheet here to understand the potential risks and benefits of taking ACTEMRA.
The information contained in this section of the site is intended for U.S. healthcare professionals only. Click "OK" if you are a healthcare professional.
The link you have selected will take you away from this site to one that is not owned or controlled by Genentech, Inc. Genentech, Inc. makes no representation as to the accuracy of the information contained on sites we do not own or control. Genentech does not recommend and does not endorse the content on any third-party websites. Your use of third-party websites is at your own risk and subject to the terms and conditions of use for such sites.